Landiolol for the prevention of postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis
ConclusionIn patients undergoing cardiac surgery, landiolol likely reduces POAF and may reduce LOS. A definitive large RCT is needed to confirm these findings.Study registrationPROSPERO (CRD42021262703); registered 25 July 2021.
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
More News: Anesthesia | Anesthesiology | Atrial Fibrillation | Beta-Blockers | Canada Health | Study